You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Glaxosmithkline Pharmaceuticals Ltd"

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 12/05/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Board to consider FY21 results & Dividend on May 18 2021

  • 03/05/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Board Meeting Intimation for Audited Financial Results (Standalone & Consolidated) For The Year Ende

  • 03/05/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 30/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

  • 27/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd SEBI Circular No. SEBJ/HO/DDHS/CIR/P/2018/144 Dated November 262018 - Fund Raising By Issuance Of De

  • 15/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd SEBI Circular No. SEBJ/HO/DDHS/CIR/P/2018/144 Dated November 262018 - Fund Raising By Issuance Of De

  • 15/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliance Of Clause 40(9) Of The Listing Obligations And Disclosure Requirements Regulations 2015 (

  • 15/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2021 (Revised)

  • 06/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Shareholding for the Period Ended March 31 2021

  • 06/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2021

  • 06/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliance Of Clause 7 (3) Of The Listing Obligations And Disclosure Requirements Regulations 2015 (

  • 05/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 05/04/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

  • 31/03/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Closure of Trading Window

  • 26/03/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 04/03/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 17/02/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release

  • 05/02/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter And Nine Months Ende

  • 05/02/2021
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter And Nine Months Ende

  • 05/02/2021
  • |
  • bse
.